Author:
Avilés-Robles Martha J.,Reyes-López Alfonso
Funder
Consejo Nacional de Ciencia y Tecnología
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Lehrnbecher T, Robinson PD, Ammann RA, Fisher B, Patel P, Phillips R, et al. Guideline for the management of Fever and Neutropenia in Pediatric patients with Cancer and hematopoietic cell transplantation recipients: 2023 update. J Clin Oncol. 2023;41(9):1774–85.
2. Santolaya ME, Contardo V, Torres JP, López-Medina E, Rosanova MT, Álvarez AM, et al. Manejo De Los episodios de neutropenia febril en niños con cáncer. Consenso De La Sociedad Latinoamericana De Infectología Pediátrica 2021 [Management of episodes of febrile neutropenia in children with cancer. Consensus of the Latin American Society of Pediatric Infectious Diseases 2021]. Rev Chil Infectol. 2021;38(6):857–909.
3. Rivas-Ruiz R, Villasis-Keever M, Miranda-Novales G, Castelán-Martínez OD, Rivas-Contreras S. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. Cochrane Database Syst Rev. 2019;3(3):CD009031.
4. Haeusler GM, Phillips R, Slavin MA, Babl FE, De Abreu Lourenco R, Mechinaud F, et al. Australian PICNICC study group and the PREDICT network. Re-evaluating and recalibrating predictors of bacterial infection in children with cancer and febrile neutropenia. EclinicalMedicine. 2020;15(23):100394.
5. Avilés-Robles M, Schnur JJ, Dorantes-Acosta E, Márquez-González H, Ocampo-Ramírez LA, Chawla NV. Predictors of septic shock or bacteremia in children experiencing febrile Neutropenia Post-chemotherapy. J Pediatr Infect Dis Soc. 2022;11(11):498–503.